Pharmacy News

Study finds lower prescription rates of SGLT-2 inhibitors and GLP-1 agonists associated with race and ethnicity

In a new study, researchers sought to examine differences in the prescribing of SGLT-2 inhibitors and glucagon-like peptide-1 (GLP-1) agonists among adults with type 2 diabetes along ethnic and racial groups. The American Diabetes Association recommends these as first-line treatments with or without metformin for people with type 2 diabetes who have or who are at high risk for atherosclerotic cardiovascular disease, heart failure, and chronic kidney disease.

New study gives insight into statins and muscle pain

While many patients who stop taking statins say that adverse effects, including muscle pain, is to blame, a new study in The Lancet says the drugs are not the cause of the pain for most statin patients reporting it.

ACIP issues recommendations on seasonal influenza vaccines

According to CDC’s 2022–2023 Advisory Committee on Immunization Practices (ACIP) recommendations, all vaccines for the approaching influenza season will be quadrivalent. Trivalent influenza vaccines have been taken out of circulation.

USPSTF updates statin recommendations for CVD prevention in adults

The U.S. Preventive Services Task Force (USPSTF) has issued new recommendations governing the use of statins for primary prevention of cardiovascular disease (CVD) in patients age 40 to 75 years with no history of CVD and no signs or symptoms of it.

Researchers examine metformin, ivermectin, and fluvoxamine for COVID-19

The research community is challenged to identify safe and effective treatments for early COVID-19 disease that patients can take at home. While monoclonal antibodies represent one option, the constant evolution of the coronavirus creates barriers.